5 days Merck Gets Positive CHMP Opinion for Keytruda in MesotheliomaZacks

The CHMP renders a positive opinion recommending approval for MRK’s Keytruda for the first-line treatment of malignant pleural mesothelioma.

Merck&Co (MRK)

20 hours Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to KnowZacks X

22 hours Goldman Sachs: Merck & Co., Inc. (MRK) Is A Top Growth Investor StockInsider Monkey X

1 day Top Analyst Reports for Broadcom, Merck & QualcommZacks X

2 days Merck & Co., Inc. (MRK) Jefferies London Healthcare ConferenceSeeking Alpha X

4 days Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’Insider Monkey X

1 week Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer TherapyZacks X

1 week Merck & Co., Inc. (MRK) UBS Global Healthcare Conference (Transcript)Seeking Alpha X

2 weeks Merck & Co., Inc. (MRK): Among the Best Low Volatility Stocks to Invest In NowInsider Monkey X

2 weeks Merck & Co., Inc. (MRK) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates EraInsider Monkey X

3 weeks Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy Right Now?Insider Monkey X

3 weeks Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in FocusZacks X

3 weeks Merck & Co., Inc. (NYSE:MRK) Trading Down 2.9% – Here’s WhyMarketBeat X

3 weeks Merck (MRK) Q3 2024 Earnings Call TranscriptThe Motley Fool X

3 weeks Merck Q3 Earnings & Sales Top, Stock Down on Lowered ’24 ViewZacks X

3 weeks Merck (MRK) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks X

3 weeks Merck & Co., Inc. (NYSE:MRK) Trading Down 0.1% – Should You Sell?MarketBeat X

3 weeks Jim Cramer Thinks That Merck & Co., Inc. (MRK) Is ‘Too Low’Insider Monkey X

4 weeks Merck & Co., Inc. (NYSE:MRK) Trading Up 0.2% – What’s Next?MarketBeat X

4 weeks Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to AnalystsInsider Monkey X

4 weeks Merck & Co., Inc. (MRK): Among the Best Stocks to Buy for High Returns in 2024Insider Monkey X

4 weeks Dumont & Blake Investment Advisors LLC Sells 5,026 Shares of Merck & Co., Inc. (NYSE:MRK)MarketBeat X

4 weeks Where Will Merck Be in 5 Years?The Motley Fool X

4 weeks Merck to Report Q3 Earnings: To Buy or Not to Buy MRK Stock?Zacks X

4 weeks Merck & Co., Inc. (NYSE:MRK) Trading Down 0.2% – Time to Sell?MarketBeat X

4 weeks Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should KnowZacks X

1 month Marks Electrical Group (LON:MRK) Reaches New 1-Year Low – Should You Sell?MarketBeat X

1 month Is Merck & Co., Inc. (NYSE:MRK) the Most Undervalued Value Stock to Buy According to Analysts?Insider Monkey X

1 month Narwhal Capital Management Buys 15,510 Shares of Merck & Co., Inc. (NYSE:MRK)MarketBeat X

1 month Merck (MRK) Advances While Market Declines: Some Information for InvestorsZacks X

1 month Zacks Research Predicts Lower Earnings for Merck & Co., Inc.MarketBeat X

1 month Merck & Co., Inc. (NYSE:MRK) Shares Bought by Vest Financial LLCMarketBeat X

1 month Top Research Reports for Visa, Netflix & MerckZacks X

1 month Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold?Zacks X

1 month Gilead, MRK Report Data From Investigational Combination Study for HIVZacks X

1 month Corundum Group Inc. Sells 6,325 Shares of Merck & Co., Inc. (NYSE:MRK)MarketBeat X

1 month Creative Planning Has $95.67 Million Position in Merck & Co., Inc. (NYSE:MRK)MarketBeat X

1 month Goldman Sachs: Merck & Co., Inc. (NYSE:MRK) Is A Stock With High Consensus ROEInsider Monkey X